<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02425202</url>
  </required_header>
  <id_info>
    <org_study_id>B2013:163</org_study_id>
    <nct_id>NCT02425202</nct_id>
  </id_info>
  <brief_title>Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy</brief_title>
  <acronym>KOSATA</acronym>
  <official_title>Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome After Tonsillectomy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate the post-operative morphine-sparing effect, pain reduction, and side
      effects of a continuous ketamine infusion after tonsillectomy in pediatric patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible pediatric patients that are undergoing tonsillectomy for sleep-disordered breathing
      or obstructive sleep apnea AND are to be admitted into a monitored setting will be recruited
      for this study. They will be randomized into two groups:1) Control group receiving continuous
      infusion of saline (placebo) and 2) Study group receiving continuous infusion of low-dose
      ketamine at 0.1 mg/kg/hr. Both patients will receive scheduled oral acetaminophen and rescue
      intravenous morphine as required. The infusions will be stopped at 0600 the next morning.
      Morphine requirements, pain scores at selected times, central nervous system side effects,
      and adverse cardiorespiratory events will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of post-operative opioid requirements after tonsillectomy in obstructive sleep apnea (OSA) patients</measure>
    <time_frame>24 hrs</time_frame>
    <description>Influence of low-dose continuous ketamine infusion on post-operative opioid requirements after tonsillectomy in OSA patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Documentation of respiratory morbidity after tonsillectomy in OSA patients</measure>
    <time_frame>24 hrs</time_frame>
    <description>Influence of low-dose ketamine infusion on respiratory morbidity after tonsillectomy in OSA patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>Ketamine infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ketamine infusion at 0.1 mg/kg/hr up to maximum of 10 mg/hr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline infusion</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Post-operative continuous infusion until 0600 the next day</description>
    <arm_group_label>Ketamine infusion</arm_group_label>
    <other_name>Ketalar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline infusion</intervention_name>
    <description>Post-operative continuous infusion until 0600 the next day</description>
    <arm_group_label>Saline infusion</arm_group_label>
    <other_name>Placebo comparator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients requiring tonsillectomy for diagnosis of sleep disordered
             breathing/obstructive sleep apnea that will be admitted for overnight
             cardiorespiratory monitoring, based on positive polysomnography test, positive
             nocturnal home oximetry, or strong signs/symptoms of OSAS

        Exclusion Criteria:

          -  Patients with significant developmental delay, abnormal airway anatomy, significant
             co-morbidities such as cardiac disorders, respiratory disorders, neurological
             disorders, anad renal disorders.

          -  Previous reaction to study medications.

          -  Postoperative bleeding within the first 24 hours

          -  Refusal to be involved in the study..
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harley Wong, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Harley Wong, MD, FRCPC</last_name>
    <phone>204-787-2560</phone>
    <email>pb221127@mymts.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Colleen Weppler, BN</last_name>
    <phone>204-787-3107</phone>
    <email>cweppler@exchange.hsc.mb.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Health Sciences Center</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3A 1S1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harley Wong, MD, FRCPC</last_name>
      <phone>204-787-2560</phone>
      <email>pb221127@mymts.net</email>
    </contact>
    <contact_backup>
      <last_name>Colleen Weppler, BN</last_name>
      <phone>204-787-3107</phone>
      <email>cweppler@exchange.hsc.mb.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Brown KA. Outcome, risk, and error and the child with obstructive sleep apnea. Paediatr Anaesth. 2011 Jul;21(7):771-80. doi: 10.1111/j.1460-9592.2011.03597.x. Epub 2011 May 3. Review.</citation>
    <PMID>21539679</PMID>
  </results_reference>
  <results_reference>
    <citation>Alexander NS, Schroeder JW Jr. Pediatric obstructive sleep apnea syndrome. Pediatr Clin North Am. 2013 Aug;60(4):827-40. doi: 10.1016/j.pcl.2013.04.009. Review.</citation>
    <PMID>23905822</PMID>
  </results_reference>
  <results_reference>
    <citation>Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, Mitchell RB, Promchiarak J, Simakajornboon N, Kaditis AG, Splaingard D, Splaingard M, Brooks LJ, Marcus CL, Sin S, Arens R, Verhulst SL, Gozal D. Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med. 2010 Sep 1;182(5):676-83. doi: 10.1164/rccm.200912-1930OC. Epub 2010 May 6.</citation>
    <PMID>20448096</PMID>
  </results_reference>
  <results_reference>
    <citation>Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg. 2003 Oct;97(4):1108-16. Review.</citation>
    <PMID>14500166</PMID>
  </results_reference>
  <results_reference>
    <citation>Baugh RF, Archer SM, Mitchell RB, Rosenfeld RM, Amin R, Burns JJ, Darrow DH, Giordano T, Litman RS, Li KK, Mannix ME, Schwartz RH, Setzen G, Wald ER, Wall E, Sandberg G, Patel MM; American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg. 2011 Jan;144(1 Suppl):S1-30. doi: 10.1177/0194599810389949.</citation>
    <PMID>21493257</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2015</study_first_submitted>
  <study_first_submitted_qc>April 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2015</study_first_posted>
  <last_update_submitted>October 27, 2016</last_update_submitted>
  <last_update_submitted_qc>October 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pediatric</keyword>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>tonsillectomy</keyword>
  <keyword>analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

